AeroPath: An airway segmentation benchmark dataset with challenging pathology and baseline method
PLOS ONE · 02.10.2024 · 19 (10) · e0311416
DOI: 10.1371/journal.pone.0311416 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 02.10.2024. Verfasst von Karen-Helene Støverud und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Research, SINTEF, Trondheim, Norway. Hauptthemen laut MEDLINE: COVID-19, Benchmarking, Tomography, X-Ray Computed. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To improve the prognosis of patients suffering from pulmonary diseases, such as lung cancer, early diagnosis and treatment are crucial. The analysis of CT images is invaluable for diagnosis, whereas high quality segmentation of the airway tree are required for intervention planning and live guidance during bronchoscopy. Recently, the Multi-domain Airway Tree Modeling (ATM’22) challenge released a large dataset, both enabling training of deep-learning based models and bringing substantial improvement of the state-of-the-art for the airway segmentation task. The ATM’22 dataset includes a large group of COVID’19 patients and a range of other lung diseases, however, relatively few patients with severe pathologies affecting the airway tree anatomy was found. In this study, we introduce a new public benchmark dataset (AeroPath), consisting of 27 CT images from patients with pathologies ranging from emphysema to large tumors, with corresponding trachea and bronchi annotations. Second, we present a multiscale fusion design for automatic airway segmentation. Models were trained on the ATM’22 dataset, tested on the AeroPath dataset, and further evaluated against competitive open-source methods. The same performance metrics as used in the ATM’22 challenge were used to benchmark the different considered approaches. Lastly, an open web application is developed, to easily test the proposed model on new data. The results demonstrated that our proposed architecture predicted topologically correct segmentations for all the patients included in the AeroPath dataset. The proposed method is robust and able to handle various anomalies, down to at least the fifth airway generation. In addition, the AeroPath dataset, featuring patients with challenging pathologies, will contribute to development of new state-of-the-art methods. The AeroPath dataset and the web application are made openly available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Health Research, SINTEF, Trondheim, Norway.
- Sopra Steria, Application Solutions, Trondheim, Norway.
- Department of Thoracic Medicine, St. Olavs Hospital, Trondheim, Norway.
- Department of Research, St. Olavs Hospital, Trondheim, Norway.
ORCID-Profile: Tore Amundsen, Thomas Langø
Zitieren
APA
Støverud, K. H., Bouget, D., Pedersen, A., Leira, H. O., Amundsen, T., Langø, T., & Hofstad, E. F. (2024). AeroPath: An airway segmentation benchmark dataset with challenging pathology and baseline method. PLOS ONE, 19(10), e0311416. https://doi.org/10.1371/journal.pone.0311416
Vancouver
Støverud KH, Bouget D, Pedersen A, Leira HO, Amundsen T, Langø T, et al. AeroPath: An airway segmentation benchmark dataset with challenging pathology and baseline method. PLOS ONE. 2024;19(10):e0311416. doi:10.1371/journal.pone.0311416
BibTeX
@article{Stverud2024,
author = {Støverud, Karen-Helene and Bouget, David and Pedersen, André and Leira, Håkon Olav and Amundsen, Tore and Langø, Thomas and Hofstad, Erlend Fagertun},
title = {AeroPath: An airway segmentation benchmark dataset with challenging pathology and baseline method},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {10},
pages = {e0311416},
doi = {10.1371/journal.pone.0311416}
}
EUVIMED